Literature DB >> 30429177

Management of asymptomatic bacteriuria in children.

Anita Dahiya, Ran D Goldman.   

Abstract

Question I am aware of how common pediatric urinary tract infection (UTI) is, and of the potential long-term sequelae if left untreated. Therefore, in our practice we treat every child who presents with symptomatic UTI with antibiotics. However, should the same practice be applied to children with bacteriuria that is asymptomatic?Answer Historically, asymptomatic bacteriuria (ABU) was treated with antibiotics in all populations, including in children. However, more recent evidence has shown no benefit and often harm associated with the use of antibiotics to treat pediatric ABU. Some studies suggest that owing to the different microbiology associated with ABU it should not be considered in the spectrum of UTI. These children should not be treated with antibiotics unless they have received a renal transplant or have undergone invasive urologic procedures. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30429177      PMCID: PMC6234948     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  26 in total

1.  Asymptomatic infections of the urinary tract.

Authors:  E H KASS
Journal:  Trans Assoc Am Physicians       Date:  1956

2.  Urinary Tract Infections in the First Year Post-Kidney Transplantation: Potential Benefits of Treating Asymptomatic Bacteriuria.

Authors:  P Kotagiri; D Chembolli; J Ryan; P D Hughes; N D Toussaint
Journal:  Transplant Proc       Date:  2017-11       Impact factor: 1.066

3.  Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection.

Authors:  Bryndís Ragnarsdóttir; Klas Jönsson; Alexander Urbano; Jenny Grönberg-Hernandez; Nataliya Lutay; Martti Tammi; Mattias Gustafsson; Ann-Charlotte Lundstedt; Irene Leijonhufvud; Diana Karpman; Björn Wullt; Lennart Truedsson; Ulf Jodal; Björn Andersson; Catharina Svanborg
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

4.  Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria.

Authors:  Bryndís Ragnarsdóttir; Martin Samuelsson; Mattias C U Gustafsson; Irene Leijonhufvud; Diana Karpman; Catharina Svanborg
Journal:  J Infect Dis       Date:  2007-06-21       Impact factor: 5.226

5.  Rare emergence of symptoms during long-term asymptomatic Escherichia coli 83972 carriage without an altered virulence factor repertoire.

Authors:  Béla Köves; Ellaine Salvador; Jenny Grönberg-Hernández; Jaroslaw Zdziarski; Björn Wullt; Catharina Svanborg; Ulrich Dobrindt
Journal:  J Urol       Date:  2013-07-30       Impact factor: 7.450

Review 6.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

7.  Controlled trial of therapy in covert bacteriuria of childhood.

Authors:  D C Savage; G Howie; K Adler; M I Wilson
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

8.  Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.

Authors:  Ki Wook Yun; Hak Young Kim; Hee Kuk Park; Wonyong Kim; In Seok Lim
Journal:  J Microbiol Immunol Infect       Date:  2013-09-21       Impact factor: 4.399

9.  Untreated asymptomatic bacteriuria in girls: II--Effect of phenoxymethylpenicillin and erythromycin given for intercurrent infections.

Authors:  S Hansson; U Jodal; K Lincoln; C Svanborg-Edén
Journal:  BMJ       Date:  1989-04-01

10.  Untreated asymptomatic bacteriuria in girls: I--Stability of urinary isolates.

Authors:  S Hansson; D Caugant; U Jodal; C Svanborg-Edén
Journal:  BMJ       Date:  1989-04-01
View more
  4 in total

1.  [Development and thoughts of digestive endoscopy in children].

Authors:  Mi-Zu Jiang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

2.  [Upper gastrointestinal ulcer in children: a clinical analysis of 173 cases].

Authors:  En-Hui Wang; Mei Sun
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

3.  In-vitro determination of antimicrobial activities of Eruca sativa seed oil against antibiotic-resistant gram-negative clinical isolates from neonates: a future prospect.

Authors:  Rasha H Bassyouni; Zeinat Kamel; Alkassem Ahmed Algameel; Ghada Ismail; Sylvana N Gaber
Journal:  BMC Complement Med Ther       Date:  2022-08-27

4.  Molecular Characterization of Uropathogenic Escherichia coli Reveals Emergence of Drug Resistant O15, O22 and O25 Serogroups.

Authors:  Ruta Prakapaite; Frederic Saab; Rita Planciuniene; Vidmantas Petraitis; Thomas J Walsh; Ruta Petraitiene; Rasa Semoskaite; Rasa Baneviciene; Lilija Kalediene; Povilas Kavaliauskas
Journal:  Medicina (Kaunas)       Date:  2019-11-11       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.